JP2002522376A5 - - Google Patents

Download PDF

Info

Publication number
JP2002522376A5
JP2002522376A5 JP2000563255A JP2000563255A JP2002522376A5 JP 2002522376 A5 JP2002522376 A5 JP 2002522376A5 JP 2000563255 A JP2000563255 A JP 2000563255A JP 2000563255 A JP2000563255 A JP 2000563255A JP 2002522376 A5 JP2002522376 A5 JP 2002522376A5
Authority
JP
Japan
Prior art keywords
xanthan gum
composition according
active ingredient
solid
solid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000563255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522376A (ja
Filing date
Publication date
Priority claimed from GBGB9816723.2A external-priority patent/GB9816723D0/en
Application filed filed Critical
Publication of JP2002522376A publication Critical patent/JP2002522376A/ja
Publication of JP2002522376A5 publication Critical patent/JP2002522376A5/ja
Pending legal-status Critical Current

Links

JP2000563255A 1998-08-01 1999-07-28 清澄キサンタンガムを含有する圧縮組成物 Pending JP2002522376A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9816723.2 1998-08-01
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents
PCT/EP1999/005499 WO2000007569A1 (en) 1998-08-01 1999-07-28 Compressed compositions comprising clarified xanthan gum

Publications (2)

Publication Number Publication Date
JP2002522376A JP2002522376A (ja) 2002-07-23
JP2002522376A5 true JP2002522376A5 (https=) 2006-06-29

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000563255A Pending JP2002522376A (ja) 1998-08-01 1999-07-28 清澄キサンタンガムを含有する圧縮組成物

Country Status (16)

Country Link
EP (1) EP1100471B1 (https=)
JP (1) JP2002522376A (https=)
CN (1) CN1160060C (https=)
AR (1) AR019981A1 (https=)
AT (1) ATE249815T1 (https=)
AU (1) AU744483B2 (https=)
CA (1) CA2339190C (https=)
DE (1) DE69911427T2 (https=)
DK (1) DK1100471T3 (https=)
ES (1) ES2207274T3 (https=)
GB (1) GB9816723D0 (https=)
MX (1) MXPA01000992A (https=)
NZ (1) NZ509593A (https=)
PT (1) PT1100471E (https=)
WO (1) WO2000007569A1 (https=)
ZA (1) ZA200100828B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ, インコーポレイティド 鎮痛薬としての使用のための6−ヒドロキシ−オキシモルホンの経口投与
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP0399774A1 (en) * 1989-05-24 1990-11-28 Merck & Co. Inc. Composition and method for rheology controlled printing of fabric and carpet

Similar Documents

Publication Publication Date Title
JP5572616B2 (ja) 口腔内分散性多層錠剤
ES2319266T3 (es) Comprimidos efervescentes bucodispersables.
AU2004202702B2 (en) Compositions comprising sympathomimetic amine salts unsuitable for illegal use
AU2004246837B2 (en) Orally-dispersible multilayer tablet
RU2007126652A (ru) Композиции и способы стабилизации активных фармацевтических ингредиентов
JP2005512995A5 (https=)
HU217818B (hu) Eljárás magas hatóanyag-tartalmú granulátumok, pelletek és tabletták előállítására
JP5137286B2 (ja) フェンタニル含有口腔粘膜貼付剤
JPH04501425A (ja) ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物
KR101367814B1 (ko) 위장체류 제제 및 이의 제조 방법
NO175763C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat hvor DL-tryptofan, eventuelt i kombinasjon med fumarsyre, anvendes som hjelpestoffer
HU202103B (en) Process for producing effervescent pharmaceutical compositions containing ibuprofen
JP2007506774A5 (https=)
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
TW200407175A (en) Dosage form of sodium IBUPROFEN
RU2005115883A (ru) Композиции с контролируемым высвобождением
JP2011148816A (ja) 口腔内速崩壊性錠
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
ES2547722T3 (es) Formulación de liberación controlada para la administración oral de metformina
JP2002522376A5 (https=)
JP2002537232A5 (https=)
JPH0617300B2 (ja) 歯周疾患治療用組成物
JPS6117510A (ja) 口腔粘膜適用徐放性ニフエジピン製剤
JP2009514857A (ja) 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法
JPS63250318A (ja) 口腔内に適用する製剤